Legato Capital Management LLC Sells 111,859 Shares of Stereotaxis, Inc. (NYSEAMERICAN:STXS)

Legato Capital Management LLC trimmed its position in Stereotaxis, Inc. (NYSEAMERICAN:STXS - Free Report) by 23.7% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 360,291 shares of the company's stock after selling 111,859 shares during the period. Legato Capital Management LLC owned approximately 0.43% of Stereotaxis worth $821,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in STXS. Jane Street Group LLC increased its holdings in shares of Stereotaxis by 26.9% in the third quarter. Jane Street Group LLC now owns 29,773 shares of the company's stock valued at $61,000 after buying an additional 6,313 shares in the last quarter. SG Americas Securities LLC raised its position in shares of Stereotaxis by 39.2% during the fourth quarter. SG Americas Securities LLC now owns 26,360 shares of the company's stock worth $60,000 after purchasing an additional 7,417 shares during the period. Wealth Effects LLC lifted its holdings in shares of Stereotaxis by 11.7% during the fourth quarter. Wealth Effects LLC now owns 86,060 shares of the company's stock valued at $196,000 after purchasing an additional 9,000 shares during the last quarter. Charles Schwab Investment Management Inc. boosted its position in shares of Stereotaxis by 10.2% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 167,297 shares of the company's stock valued at $341,000 after purchasing an additional 15,491 shares during the period. Finally, State Street Corp increased its stake in Stereotaxis by 5.7% in the 3rd quarter. State Street Corp now owns 680,612 shares of the company's stock worth $1,388,000 after purchasing an additional 36,518 shares in the last quarter. 45.35% of the stock is owned by institutional investors.

Stereotaxis Price Performance

Shares of STXS traded down $0.01 during trading hours on Monday, reaching $2.26. The company's stock had a trading volume of 395,689 shares, compared to its average volume of 353,791. The company has a market capitalization of $191.49 million, a price-to-earnings ratio of -8.07 and a beta of 1.54. Stereotaxis, Inc. has a 1-year low of $1.66 and a 1-year high of $3.29.

About Stereotaxis

Stereotaxis, Inc designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. Its robotic magnetic navigation (RMN) systems include the Genesis RMN and Niobe systems, which enable physicians to complete complex interventional procedures by providing image-guided delivery of catheters and guidewires through the blood vessels and chambers of the heart to treatment sites.